Cargando…

Mithramycin selectively attenuates DNA-damage-induced neuronal cell death

DNA damage triggers cell death mechanisms contributing to neuronal loss and cognitive decline in neurological disorders, including traumatic brain injury (TBI), and as a side effect of chemotherapy. Mithramycin, which competitively targets chromatin-binding sites of specificity protein 1 (Sp1), was...

Descripción completa

Detalles Bibliográficos
Autores principales:	Makarevich, Oleg, Sabirzhanov, Boris, Aubrecht, Taryn G., Glaser, Ethan P., Polster, Brian M., Henry, Rebecca J., Faden, Alan I., Stoica, Bogdan A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7385624/ https://www.ncbi.nlm.nih.gov/pubmed/32719328 http://dx.doi.org/10.1038/s41419-020-02774-6

Ejemplares similares

Comparing effects of CDK inhibition and E2F1/2 ablation on neuronal cell death pathways in vitro and after traumatic brain injury
por: Aubrecht, Taryn G., et al.
Publicado: (2018)

Down-Regulation of miR-23a-3p Mediates Irradiation-Induced Neuronal Apoptosis
por: Sabirzhanov, Boris, et al.
Publicado: (2020)

Irradiation-Induced Upregulation of miR-711 Inhibits DNA Repair and Promotes Neurodegeneration Pathways
por: Sabirzhanov, Boris, et al.
Publicado: (2020)

Inhibition of E2F1/CDK1 Pathway Attenuates Neuronal Apoptosis In Vitro and Confers Neuroprotection after Spinal Cord Injury In Vivo
por: Wu, Junfang, et al.
Publicado: (2012)

Proton extrusion during oxidative burst in microglia exacerbates pathological acidosis following traumatic brain injury
por: Ritzel, Rodney M., et al.
Publicado: (2020)

Inhibition of microRNA-711 limits angiopoietin-1 and Akt changes, tissue damage, and motor dysfunction after contusive spinal cord injury in mice
por: Sabirzhanov, Boris, et al.
Publicado: (2019)

Impaired autophagy flux is associated with neuronal cell death after traumatic brain injury
por: Sarkar, Chinmoy, et al.
Publicado: (2015)

Interaction of high-fat diet and brain trauma alters adipose tissue macrophages and brain microglia associated with exacerbated cognitive dysfunction
por: Henry, Rebecca J., et al.
Publicado: (2023)

Mithramycin and Analogs for Overcoming Cisplatin Resistance in Ovarian Cancer
por: Schweer, David, et al.
Publicado: (2021)

Nanoparticulate formulations of mithramycin analogs for enhanced cytotoxicity
por: Scott, Daniel, et al.
Publicado: (2011)

A trial of mithramycin in the treatment of advanced malignant disease.
por: Sewell, I. A., et al.
Publicado: (1966)

Mithramycin interacts with core histones and modulates epigenetic modifications
por: Banerjee, Amrita, et al.
Publicado: (2013)

Mithramycin delivery systems to develop effective therapies in sarcomas
por: Estupiñán, Óscar, et al.
Publicado: (2021)

Mithramycin induces promoter reprogramming and differentiation of rhabdoid tumor
por: Chasse, Maggie H, et al.
Publicado: (2020)

Structures of mithramycin analogues bound to DNA and implications for targeting transcription factor FLI1
por: Hou, Caixia, et al.
Publicado: (2016)

A clinical trial of mithramycin in the treatment of advanced malignant disease.
por: Baum, M.
Publicado: (1968)

Nano-Encapsulation of Mithramycin in Transfersomes and Polymeric Micelles for the Treatment of Sarcomas
por: Estupiñán, Óscar, et al.
Publicado: (2021)

Delayed microglial depletion after spinal cord injury reduces chronic inflammation and neurodegeneration in the brain and improves neurological recovery in male mice
por: Li, Yun, et al.
Publicado: (2020)

Mithramycin Treatment of Hypercalcaemia and Renal Failure in a Patient with Paratesticular Embryonic Sarcoma
por: Parsons, V., et al.
Publicado: (1971)

Letter: Renal function and electrolyte disturbances in normocalcaemic and hypercalcaemic patients treated with mithramycin.
por: Fillastre, J. P., et al.
Publicado: (1974)

Mithramycin A Inhibits Colorectal Cancer Growth by Targeting Cancer Stem Cells
por: Quarni, Waise, et al.
Publicado: (2019)

Entropically-driven binding of mithramycin in the minor groove of C/G-rich DNA sequences
por: Barceló, Francisca, et al.
Publicado: (2007)

Mithramycin downregulates proinflammatory cytokine-induced matrix metalloproteinase gene expression in articular chondrocytes
por: Liacini, Abdelhamid, et al.
Publicado: (2005)

Mithramycin encapsulated in polymeric micelles by microfluidic technology as novel therapeutic protocol for beta-thalassemia
por: Capretto, Lorenzo, et al.
Publicado: (2012)

Mithramycin A Alleviates Osteoarthritic Cartilage Destruction by Inhibiting HIF-2α Expression
por: Choi, Moon-Chang, et al.
Publicado: (2018)

Heterologous reconstitution of the biosynthesis pathway for 4-demethyl-premithramycinone, the aglycon of antitumor polyketide mithramycin
por: Zabala, Daniel, et al.
Publicado: (2020)

Targeting the Spike: Repurposing Mithramycin and Dihydroergotamine to Block SARS-CoV-2 Infection
por: Stagnoli, Soledad, et al.
Publicado: (2023)

The addition of arginine deiminase potentiates Mithramycin A-induced cell death in patient-derived glioblastoma cells via ATF4 and cytochrome C
por: Linke, Charlotte, et al.
Publicado: (2023)

Genome-Wide Modulation of Gene Transcription in Ovarian Carcinoma Cells by a New Mithramycin Analogue
por: Vizcaíno, Carolina, et al.
Publicado: (2014)

Anticancer drug mithramycin interacts with core histones: An additional mode of action of the DNA groove binder
por: Banerjee, Amrita, et al.
Publicado: (2014)

Modulation of specificity protein 1 by mithramycin A as a novel therapeutic strategy for cervical cancer
por: Choi, Eun-Sun, et al.
Publicado: (2014)

Aminochalcones Attenuate Neuronal Cell Death under Oxidative Damage via Sirtuin 1 Activity
por: Apiraksattayakul, Setthawut, et al.
Publicado: (2023)

The anticancer drug mithramycin A sensitises tumour cells to apoptosis induced by tumour necrosis factor (TNF)
por: Duverger, V, et al.
Publicado: (2004)

Inhibition of SP1 by the mithramycin analog EC-8042 efficiently targets tumor initiating cells in sarcoma
por: Tornin, Juan, et al.
Publicado: (2016)

Mithramycin-loaded mPEG-PLGA nanoparticles exert potent antitumor efficacy against pancreatic carcinoma
por: Liu, Xu-Jie, et al.
Publicado: (2017)

Combination Therapy of Mithramycin A and Immune Checkpoint Inhibitor for the Treatment of Colorectal Cancer in an Orthotopic Murine Model
por: Dutta, Rinku, et al.
Publicado: (2021)

NOX2 deficiency alters macrophage phenotype through an IL-10/STAT3 dependent mechanism: implications for traumatic brain injury
por: Barrett, James P., et al.
Publicado: (2017)

Delayed mGluR5 activation limits neuroinflammation and neurodegeneration after traumatic brain injury
por: Byrnes, Kimberly R, et al.
Publicado: (2012)

Modulation of the Activity of Sp Transcription Factors by Mithramycin Analogues as a New Strategy for Treatment of Metastatic Prostate Cancer
por: Malek, Anastasia, et al.
Publicado: (2012)

Mithramycin Targets Sp1 and The Androgen Receptor Transcription Level—Potential Therapeutic Role in Advanced Prostate Cancer
por: Wang, Long G., et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_0fpijp1ijiaah950g8grp934vc